| Literature DB >> 30115933 |
Junyou Wang1, Bo Shao1, Xijun He1, Yongqiang Zhang2, Li Zhang2, Tian Jiang3, Jinzhong Xu4, Youxin Wang5, Jing Wu6, Yong Zhou7, Junzheng Chen8, Lingfang Teng9.
Abstract
The cardiovascular health (CVH) metrics are closely related to the risk of stroke. Extracranial carotid artery stenosis (ECAS) represents an important risk factor for ischemic stroke. The present study aims to explore the longitudinal effect of the baseline CVH metrics on the development of ECAS. Totally 5,440 participants were randomly enrolled in the Asymptomatic Polyvascular Abnormalities Community study from 2010 to 2011. Information regarding the seven CVH metrics was collected at baseline. ECAS was assessed by performing carotid duplex sonography at baseline (2010-2011) and during the follow-up (2012-2013). Finally 3,487 subjects were included, and 976 participants developed ECAS during the 2-year follow-up. The optimum CVH status was associated with a 42% (95% confidence interval: 0.40-0.85) decreased risk of the incidence of ECAS after adjusting for age, sex, weight, education, income, alcohol use, waist-hip ratio, triglycerides, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, uric acid, homocysteine, and C-reactive protein. Ideal physical activity, total cholesterol and fasting blood glucose were independent protective factors of ECAS. In this cohort study, the ideal baseline CVH status was negatively associated with the occurrence of ECAS during the follow-up. This study provides practical insight for further developing effective screening strategies or implementing the best medical treatment.Entities:
Year: 2018 PMID: 30115933 PMCID: PMC6095842 DOI: 10.1038/s41598-018-29754-3
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Baseline characteristic comparisons among the participant with the different CVH scores.
| Total (n = 3487) | Inadequate (0~4 points) | Average (5~9 points) | Optimum (10~14 points) |
| |
|---|---|---|---|---|---|
| n = 101 | n = 2124 | n = 1262 | |||
| Age, years | 53.9 ± 10.7 | 55.2 ± 10.1 | 55.6 ± 10.8 | 51.0 ± 10.0 | <0.001 |
| Sex, % | <0.001 | ||||
| Female | 1554 (44.6) | 8 (8.0) | 664 (31.3) | 882 (69.9) | |
| Male | 1993 (55.4) | 93 (92.1) | 1460 (68.7) | 380 (30.1) | |
| Body weight, kg | 69.0 ± 11.0 | 81.5 ± 10.9 | 71.7 ± 10.6 | 63.3 ± 9.0 | <0.001 |
| Education level, % | <0.001 | ||||
| Illiterate/primary school | 343 (9.8) | 11 (10.9) | 242 (11.4) | 90 (7.1) | |
| Middle school | 1483 (42.5) | 48 (47.5) | 954 (44.9) | 481 (38.1) | |
| High school or above | 1660 (47.6) | 42 (41.6) | 927 (43.7) | 691 (54.8) | |
| Income, ¥/month, % | 0.007 | ||||
| <¥1000 | 729 (20.9) | 12 (11.9) | 428 (20.2) | 289 (22.9) | |
| ¥1001 to ¥3000 | 2309 (66.3) | 73 (72.3) | 1399 (65.9) | 837 (66.3) | |
| ≥¥3000 | 447 (12.8) | 16 (15.8) | 295 (13.9) | 136 (10.8) | |
| Alcohol use, % | <0.001 | ||||
| Yes | 474 (13.6) | 40 (39.6) | 380 (17.9) | 54 (4.3) | |
| No | 3013 (86.4) | 61 (60.4) | 1744 (82.1) | 1208 (95.7) | |
| Waist-hip ratio | 0.9 ± 0.1 | 0.9 ± 0.0 | 0.9 ± 0.1 | 0.9 ± 0.1 | <0.001 |
| TG, mmol/L | 1.7 ± 1.5 | 3.2 ± 3.1 | 1.8 ± 1.5 | 1.4 ± 1.1 | <0.001 |
| LDL-C, mmol/L | 2.6 ± 0.8 | 3.2 ± 1.0 | 2.7 ± 0.8 | 2.4 ± 0.6 | <0.001 |
| HDL-C, mmol/L | 1.6 ± 0.5 | 1.6 ± 0.4 | 1.6 ± 0.4 | 1.7 ± 0.5 | <0.001 |
| UA, μmol/L | 289.4 ± 89.6 | 337.4 ± 92.9 | 304.3 ± 90.4 | 260.4 ± 79.5 | <0.001 |
| Homocysteine, mol/L | 15.2 ± 9.2 | 17.1 ± 9.2 | 16.4 ± 9.5 | 13.0 ± 8.1 | <0.001 |
| CRP, mg/dL | 2.0 ± 3.9 | 2.9 ± 2.7 | 2.3 ± 4.4 | 1.5 ± 2.7 | <0.001 |
Abbreviations: CVH, cardiovascular health; ¥, Yuan; TG, triglycerides; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; UA, uric acid; CRP, C-reactive protein.
Distribution of baseline cardiovascular health metrics between the participants who developed into ECAS or not in two-year follow-up.
| Total (n = 3487) | ECAS |
| ||
|---|---|---|---|---|
| Yes (n = 976) | No (n = 2511) | |||
| Smoking | <0.001 | |||
| Ideal | 2251 (64.6) | 570 (58.4) | 1681 (67.0) | |
| Intermediate | 183 (5.2) | 85(8.7) | 98 (3.9) | |
| Poor | 1053 (30.2) | 321 (32. 9) | 732 (29.2) | |
| BMI | 0.045 | |||
| Ideal | 1862 (53.4) | 493 (50.5) | 1369 (54.5) | |
| Intermediate | 1410 (40.4) | 427 (43.8) | 983 (39.2) | |
| Poor | 215 (6.2) | 56 (5.7) | 159 (6.3) | |
| Physical exercise | <0.001 | |||
| Ideal | 1361 (39.0) | 306 (31.4) | 1055 (42.0) | |
| Intermediate | 915 (26.2) | 206 (21.1) | 709 (28.2) | |
| Poor | 1211 (34.7) | 464 (47.5) | 747 (29.8) | |
| Salt intake | 0.011 | |||
| Ideal | 738 (21.2) | 191 (19.6) | 547 (21.8) | |
| Intermediate | 2046 (58.7) | 557 (57.1) | 1489 (59.3) | |
| Poor | 703 (20.2) | 228 (23.4) | 475 (18.9) | |
| TC | <0.001 | |||
| Ideal | 2053 (58.9) | 455 (46.6) | 1598 (63.6) | |
| Intermediate | 1024 (29.4) | 356 (36.5) | 668 (26.6) | |
| Poor | 410 (11.8) | 165 (16.9) | 245 (9.8) | |
| BP | <0.001 | |||
| Ideal | 688 (19.7) | 121 (12.4) | 567 (22.6) | |
| Intermediate | 1139 (32.7) | 365 (37.4) | 774 (30.8) | |
| Poor | 1660 (47.6) | 490 (50.2) | 1170 (46.6) | |
| FBG | <0.001 | |||
| Ideal | 2394 (68.7) | 619 (63.4) | 1775 (70.7) | |
| Intermediate | 787 (22.6) | 231 (23.7) | 556 (22.1) | |
| Poor | 306 (8.8) | 126 (12.9) | 180 (7.2) | |
| CVH score | 8.7 ± 2.2 | 7.8 ± 2.0 | 9.0 ± 2.2 | <0.001 |
| 0–4 points | 101 (2.9) | 41 (4.2) | 60 (2.4) | <0.001 |
| 5–9 points | 2124 (60.9) | 720 (73.8) | 1404 (55.9) | |
| 10–14 points | 1262 (36.2) | 215 (22.0) | 1047 (41.7) | |
Abbreviations: ECAS, extracranial carotid artery stenosis; BMI, body mass index; TC, total cholesterol; BP, blood pressure; FBG, fasting plasma glucose; CVH, cardiovascular health.
The hazard ratio together with 95% confidence interval of the incident ECAS according to the summary CVH score in northern Han Chinese.
| Inadequate (0~4 points) | Average (5~9 points) | Optimum (10~14 points) | |||
|---|---|---|---|---|---|
| HR (95% CI) |
| HR (95% CI) |
| ||
| Model 1 | ref | 0.63 (0.45, 0.86) | 0.004 | 0.32 (0.23, 0.45) | <0.001 |
| Model 2 | ref | 0.66 (0.48, 0.92) | 0.013 | 0.49 (0.34, 0.69) | <0.001 |
| Model 3 | ref | 0.69 (0.50, 0.97) | 0.032 | 0.54 (0.38, 0.78) | 0.001 |
| Model 4 | ref | 0.73 (0.52, 1.03) | 0.073 | 0.58 (0.40, 0.85) | 0.005 |
Model 1: unadjusted.
Model 2: adjusted for age and sex.
Model 3: adjusted for age, sex, weight, education, income, alcohol use, and waist-hip ratio.
Model 4: adjusted for age, sex, weight, education, income, alcohol use, waist-hip ratio, TG, LDL-C, HDL-C, UA, homocysteine, and CRP.
Abbreviations: ECAS, extracranial carotid artery stenosis; CVH, cardiovascular health; HR: hazard ratio; CI: confidence interval; TG, triglycerides; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; UA, uric acid; CRP, C-reactive protein.
Risk of ECAS according to each CVH metric at baseline.
| Crude model | Adjusted model | |||||
|---|---|---|---|---|---|---|
| HR | 95% CI |
| HR | 95% CI |
| |
| Smoking | ||||||
| Ideal | ref | ref | ||||
| Intermediate | 2.11 | 1.68–2.67 | <0.001 | 1.15 | 0.90–1.47 | 0.266 |
| Poor | 1.14 | 0.99–1.30 | 0.070 | 0.96 | 0.82–1.13 | 0.619 |
| BMI | ||||||
| Ideal | ref | ref | ||||
| Intermediate | 1.09 | 0.95–1.24 | 0.209 | 1.03 | 0.90–1.18 | 0.695 |
| Poor | 0.97 | 0.74–1.28 | 0.840 | 1.04 | 0.78–1.38 | 0.778 |
| Physical exercise | ||||||
| Ideal | ref | |||||
| Intermediate | 0.94 | 0.78–1.12 | 0.530 | 0.97 | 0.81–1.17 | 0.777 |
| Poor | 1.68 | 1.45–1.95 | <0.001 | 1.26 | 1.08–1.47 | 0.003 |
| Salt intake | ||||||
| Ideal | ref | |||||
| Intermediate | 1.03 | 0.87–1.22 | 0.138 | 1.09 | 0.92–1.29 | 0.300 |
| Poor | 1.20 | 0.99–1.45 | 0.071 | 1.17 | 0.96–1.43 | 0.129 |
| TC | ||||||
| Ideal | ref | |||||
| Intermediate | 1.73 | 1.50–1.99 | <0.001 | 1.54 | 1.33–1.78 | <0.001 |
| Poor | 1.91 | 1.60–2.29 | <0.001 | 1.64 | 1.37–1.97 | <0.001 |
| BP | ||||||
| Ideal | ref | |||||
| Intermediate | 1.95 | 1.59–2.40 | <0.001 | 1.14 | 0.92–1.42 | 0.223 |
| Poor | 1.80 | 1.48–2.20 | <0.001 | 1.01 | 0.82–1.25 | 0.893 |
| FBG | ||||||
| Ideal | ref | |||||
| Intermediate | 1.29 | 1.11–1.51 | 0.001 | 1.29 | 1.11–1.51 | 0.001 |
| Poor | 1.59 | 1.31–1.93 | <0.001 | 1.25 | 1.02–1.52 | 0.028 |
Adjusted model for sex, age, and the other six CVH metrics (TC, BP, FBG, smoking, BMI, physical activity, and salt intake).
Abbreviations: ECAS, extracranial carotid artery stenosis; CVH, cardiovascular health; HR: hazard ratio; CI: confidence interval; BMI, body mass index; TC, total cholesterol; BP, blood pressure; FBG, fasting plasma glucose.
Figure 1Flow chart of the study to show the selection of APAC study participants for analysis. Abbreviations: APAC, Asymptomatic Polyvascular Abnormalities Community; ECAS, extracranial carotid artery stenosis; CVH, cardiovascular health.
Comparisons of baseline data between the participants included in the final analysis and these lost to follow-up.
| Participated in study (n = 3487) | Lost to follow-up (n = 1561) |
| |
|---|---|---|---|
| Age, years | 53.9 ± 10.7 | 56.7 ± 12.7 | <0.001 |
| Sex, % | |||
| Female | 1554 (44.6) | 557 (35.7) | <0.001 |
| Male | 1933 (55.4) | 1004 (64.3) | |
| Body weight, kg | 69.0 ± 11.0 | 69.5 ± 11.0 | 0.127 |
| Education level, % | |||
| Illiterate/primary school | 343 (9.8) | 254 (16.3) | <0.001 |
| Middle school | 1483 (42.5) | 752 (48.2) | |
| High school or above | 1660 (47.6) | 555 (35.6) | |
| Income, ¥/month, % | |||
| <¥1000 | 729 (21.0) | 354 (22.7) | 0.693 |
| ¥1001 to ¥3000 | 2309 (66.3) | 1039 (66.6) | |
| ≥¥3000 | 447 (12.8) | 168 (10.8) | |
| Smoking, % | |||
| Yes | 1053 (30.2) | 505 (32.4) | 0.126 |
| No | 2434 (69.8) | 1056 (67.7) | |
| Alcohol use, % | |||
| Yes | 474 (13.6) | 239 (15.3) | 0.105 |
| No | 3013 (86.4) | 1322 (84.7) | |
| Waist-hip ratio | 0.9 ± 0.1 | 0.9 ± 0.1 | <0.001 |
| BMI, kg/m2 | 25.0 ± 3.2 | 25.1 ± 3.4 | 0.144 |
| TC, mmol/L | 5.1 ± 1.0 | 5.1 ± 1.0 | 0.456 |
| TG, mmol/L | 1.7 ± 1.5 | 1.7 ± 1.3 | 0.183 |
| LDL-C, mmol/L | 2.6 ± 0. 8 | 2.6 ± 0.8 | 0.624 |
| HDL-C, mmol/L | 1.6 ± 0.5 | 1.6 ± 0.4 | 0.115 |
| FBG, mg/dL | 99.5 ± 26.1 | 102.3 ± 29.1 | 0.001 |
| SBP, mmHg | 129.5 ± 19.4 | 134.1 ± 20.5 | <0.001 |
| DBP, mmHg | 82.7 ± 11.0 | 83.7 ± 11.2 | 0.004 |
| UA, μmol/L | 289.4 ± 89.6 | 285.4 ± 90.2 | 0.150 |
| Homocysteine, μmol/L | 15.2 ± 9.2 | 16.8 ± 10.3 | <0.001 |
| CRP, mg/dL | 1.0 (0.5, 2.1) | 1.0 (0.6, 2.2) | 0.003 |
| CVH score | |||
| 0–4 points | 101 (2.9) | 50 (3.2) | 0.001 |
| 5–9 points | 2124 (60.9) | 1031 (66.1) | |
| 10–14 points | 1262 (36.2) | 480 (30.8) | |
Abbreviations: ¥, Yuan; BMI, body mass index; TC, total cholesterol; TG, triglycerides; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; FBG, fasting plasma glucose; SBP, systolic blood pressure; DBP, diastolic blood pressure; UA, uric acid; CRP, C-reactive protein; CVH, cardiovascular health.